Human Papillomavirus Prevalence Among Australian Men Aged 18–35 Years in 2015–2018 According to Vaccination Status and Sexual Orientation

• DOI: 10.1093/infdis/jiae412
• Publication Date: 2024-08-30T20:11:05Z
• Authors: Prisha Balgovind; Eithandee Aung; Hannah Shilling; Gerald L Murray; Monica Molano; Suzanne M Garland; Christopher K Fai...; Marcus Y Chen; Jane S Hocking; Catriona Ooi; Anna McNulty; Jenny McCloskey; Kathleen McNamee; Deborah Bateson; Louise Owen; Sepehr N Tabrizi; Dorothy A Machalek
• Keywords: 0303 health sciences; 03 medical and health sciences

Australia introduced a national human papillomavirus (HPV) vaccination program for girls in 2007 and boys 2013, achieving high coverage. We assessed HPV prevalence among men who have sex with women (MSW) (MSM) aged 18-35 years examined effects. Between 2015-2018, self-collected penile or intra-anal swab genotyping. Vaccination status was confirmed the National Register. by age groups status. Prevalence of quadrivalent vaccine-targeted types (6, 11, 16, 18) 10.6% (95% confidence interval [CI], 8.7%-12.8%) unvaccinated MSW 10.7% CI, 5.7%-19.3%) vaccinated (P = .96). 40.3% 36.0%-44.8%) MSM 29.9% 23.1%-37.8%) .02). Among those doses, were detected 0% 0%-7.7%; n 46) had their first dose at 13-19 37.2% 27.5%-47.8%; 94) received 20 older. Our data demonstrate importance universal adolescent to ensure receive same benefits as MSW.